Acute Myocardial Infarction (Heart Attack) – A Complete Guide
Overview
Acute myocardial infarction (AMI), commonly known as a heart attack, occurs when blood flow to a portion of the heart muscle is abruptly blocked, leading to ischemia and necrosis of cardiac tissue. It is a medical emergency that accounts for roughly ≈ 7.3 million cases worldwide each year, making it one of the leading causes of death and disability globally [1].
While AMI can affect anyone, its incidence rises sharply after the fifth decade of life. In the United States, about 790,000 heart attacks are reported annually, with men experiencing them roughly 2‑3 times more often than women before age 55, but the gender gap narrows after menopause [2].
Symptoms
Symptoms can vary by age, sex, and whether the infarction is “ST‑segment elevation” (STEMI) or “non‑ST‑segment elevation” (NSTEMI). Below is a comprehensive list:
Classic (typical) symptoms
- Chest discomfort – pressure, squeezing, heaviness, or a feeling of “tightness” lasting >5 minutes, often radiating to the left arm, neck, jaw, or back.
- Shortness of breath – sudden difficulty breathing, even at rest.
- Cold sweats – clammy skin without an obvious cause.
- nausea or vomiting – especially in women and younger adults.
- Light‑headedness or fainting – due to reduced cardiac output.
Atypical symptoms
- Fatigue or unexplained weakness (more common in older adults).
- Upper‑abdominal discomfort or indigestion‑like pain.
- Jaw, neck, or back pain without chest pain.
- Sudden anxiety or a feeling of impending doom.
- Persistent cough or wheezing.
Women, diabetics, and older adults are more likely to present with atypical symptoms, which can delay recognition and treatment [3].
Causes and Risk Factors
Primary cause
The most common mechanism is a ruptured atherosclerotic plaque in a coronary artery that triggers a thrombus (blood clot), completely or partially occluding blood flow. Rarely, a coronary artery spasm, embolus, or traumatic injury can cause AMI.
Major modifiable risk factors
- Smoking – doubles the risk; each pack‑year adds 14 % risk.
- Hypertension – chronic high pressure damages arterial walls.
- High LDL cholesterol – promotes plaque formation.
- Diabetes mellitus – accelerates atherosclerosis.
- Obesity – especially central (visceral) obesity.
- Physical inactivity – low cardiorespiratory fitness is linked to a 30‑40 % higher risk.
- Unhealthy diet – high saturated fat, trans‑fat, and sodium intake.
Non‑modifiable risk factors
- Age – risk roughly doubles each decade after 45 y (men) and 55 y (women).
- Sex – men are at higher risk earlier; post‑menopausal women catch up.
- Family history – first‑degree relative with premature coronary disease (<55 y for men, <65 y for women).
- Genetic predispositions – e.g., familial hypercholesterolemia.
- Ethnicity – South Asian, African‑American, and Hispanic populations have higher incidence.
Diagnosis
Rapid diagnosis is essential to restore perfusion and limit myocardial damage.
1. Clinical assessment
- History of symptom onset, character, and radiation.
- Physical exam – looking for signs of heart failure (e.g., rales, S3 gallop) or shock.
2. Electrocardiogram (ECG)
A 12‑lead ECG performed within 10 minutes of presentation is the cornerstone. Findings include:
- ST‑segment elevation ≥1 mm in two contiguous leads – indicates STEMI.
- ST‑segment depression, T‑wave inversion, or new left‑bundle‑branch block – suggest NSTEMI or unstable angina.
3. Cardiac biomarkers
Troponin I or T is the most sensitive and specific marker. Levels rise 3–6 hours after onset, peak at 12–24 hours, and may remain elevated for up to 14 days. Creatine kinase‑MB (CK‑MB) is used less frequently now but can support diagnosis.
4. Imaging
- Echocardiography – assesses wall‑motion abnormalities, ejection fraction, and complications (e.g., ventricular septal rupture).
- Coronary angiography – gold standard for visualizing occluded vessels; also therapeutic (PCI).
- CT coronary angiography – useful in low‑risk patients when invasive angiography is not immediately needed.
5. Risk‑stratification scores
Tools such as the TIMI (Thrombolysis In Myocardial Infarction) score and GRACE (Global Registry of Acute Coronary Events) score help determine intensity of therapy and prognosis [4].
Treatment Options
Therapy aims to (1) restore coronary blood flow, (2) limit infarct size, and (3) prevent complications.
1. Immediate (pre‑hospital) care
- Aspirin 162–325 mg chewable – irreversible platelet inhibition.
- Sublingual nitroglycerin for chest discomfort (unless hypotensive).
- Oxygen only if SpO₂ < 90 %.
- Rapid transport to a PCI‑capable hospital (goal door‑to‑balloon ≤90 minutes for STEMI).
2. Reperfusion strategies
- Primary percutaneous coronary intervention (PCI) – mechanical opening of the artery with a stent; preferred if available within guideline time frames.
- Fibrinolytic therapy – alteplase, reteplase, or tenecteplase; used when PCI cannot be performed within 120 minutes.
3. Pharmacologic therapy (post‑reperfusion)
- Antiplatelet agents – clopidogrel, ticagrelor, or prasugrel (dual antiplatelet therapy for at least 12 months).
- Anticoagulants – unfractionated heparin, low‑molecular‑weight heparin, or bivalirudin during/after PCI.
- Beta‑blockers – reduce myocardial oxygen demand; start within 24 h unless contraindicated.
- ACE inhibitors or ARBs – improve remodeling, especially in patients with LV dysfunction.
- Statins – high‑intensity therapy (e.g., atorvastatin 80 mg) initiated early and continued lifelong.
- Aliskiren, neprilysin inhibitors – used selectively in heart‑failure subsets.
4. Surgical options
- Coronary artery bypass grafting (CABG) – considered for multi‑vessel disease, left main disease, or when PCI is unsuitable.
5. Lifestyle and secondary‑prevention measures
- Smoking cessation, weight management, regular aerobic exercise (≥150 min/week), Mediterranean‑style diet, and glycemic control.
- Cardiac rehabilitation programs (phase I–III) improve survival and quality of life [5].
Living with Acute Myocardial Infarction
Medication adherence
Use a pill organizer, set alarms, and keep a medication list. Never stop a drug abruptly without consulting your cardiologist.
Monitoring & follow‑up
- First cardiology visit within 1 week of discharge.
- Repeat ECG and echocardiogram at 4–6 weeks to assess ejection fraction.
- Routine blood work for lipids, kidney function, and HbA1c (if diabetic).
Physical activity
Start with light walking under supervision; progress to moderate‑intensity aerobic activity as tolerated. Avoid heavy lifting or competitive sports for at least 3 months unless cleared.
Dietary recommendations
- Focus on fruits, vegetables, whole grains, legumes, nuts, and fatty fish.
- Limit saturated fat (<7 % of total calories), trans‑fat, added sugars, and sodium (<1,500 mg/day).
Psychological health
Post‑MI depression and anxiety affect up to 25 % of patients. Seek counseling, support groups, or cognitive‑behavioral therapy when needed.
Red‑flag symptoms to watch
- Re‑onset of chest pressure or new shortness of breath.
- Palpitations, sudden weakness, or fainting.
- Persistent swelling of legs (possible heart failure).
Prevention
Primary prevention focuses on risk‑factor modification before the first event; secondary prevention aims to stop recurrence.
Key preventive strategies
- Blood pressure control – target <130/80 mmHg (or <120/80 mmHg in high‑risk individuals) per ACC/AHA guidelines [6].
- Lipid management – LDL‑C <70 mg/dL for secondary prevention; <190 mg/dL> for primary prevention warrants high‑intensity statin.
- Diabetes control – HbA1c <7 % (individualized).
- Smoking cessation – nicotine replacement, varenicline, or bupropion.
- Regular physical activity – at least 150 min/week moderate‑intensity aerobic exercise.
- Weight management – BMI 18.5–24.9 kg/m²; waist circumference < 40 in (men) / < 35 in (women).
- Stress reduction – mindfulness, yoga, or counseling.
Complications
If the infarct is large or treatment is delayed, several life‑threatening complications can arise:
- Cardiogenic shock – severe pump failure; mortality > 50 % without rapid intervention.
- Arrhythmias – ventricular tachycardia/fibrillation (most common cause of sudden death).
- Heart failure – reduced ejection fraction leading to chronic symptoms.
- Mechanical complications – ventricular septal rupture, papillary‑muscle rupture (mitral regurgitation), free‑wall rupture.
- Left‑ventricular aneurysm – dyskinetic segment that may lead to thrombus formation.
- Re‑infarction – new occlusion in the same or different coronary territory.
- Stroke – due to embolization from ventricular thrombus or atrial fibrillation.
When to Seek Emergency Care
- Sudden, crushing or squeezing chest pain lasting > 5 minutes, especially if it spreads to the left arm, neck, jaw, or back.
- Unexplained shortness of breath, especially at rest.
- Severe, sudden weakness, fainting, or confusion.
- Profuse sweating, nausea, or vomiting with chest discomfort.
- New or worsening heart palpitations or a feeling of “fluttering.”
- Sudden onset of severe anxiety or a sense of impending doom.
Do not wait for symptoms to resolve; timely treatment dramatically improves survival.
References
- World Health Organization. Cardiovascular diseases (CVDs) fact sheet. 2023.
- American Heart Association. Heart disease and stroke statistics—2024 update. Circulation. 2024.
- Barshes NR, et al. Sex differences in presentation of acute myocardial infarction. JAMA Cardiology. 2022.
- Antman EM, et al. ACC/AHA Guidelines for the Management of Patients With ST‑Elevation Myocardial Infarction. Circulation. 2023.
- Anderson L, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease. Cochrane Review. 2021.
- Whelton PK, et al. 2023 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2023.